Cost–Utility and Budget Impact Analyses of Oral Chemotherapy for Stage III Colorectal Cancer: Real-World Evidence after Policy Implementation in Thailand
P Phisalprapa, C Kositamongkol, K Korphaisarn… - Cancers, 2023 - mdpi.com
Simple Summary There are various chemotherapy regimens used to treat patients
diagnosed with stage III colorectal cancer, one of which is an oral chemotherapy drug called …
diagnosed with stage III colorectal cancer, one of which is an oral chemotherapy drug called …
Perceptions of and Preparedness for the Application of Pharmacoeconomics in Practice, among Final Year Bachelor of Pharmacy Students in South Africa: A National …
For the improvement of access to health, many countries including South Africa, have
adopted universal healthcare. However, this requires skills to apply health technology …
adopted universal healthcare. However, this requires skills to apply health technology …
Cost-effectiveness of pembrolizumab as an adjuvant treatment of renal cell carcinoma post-nephrectomy in Switzerland
N Schur, A Favre-Bulle, M Flori, Y Xiao… - Journal of Medical …, 2024 - Taylor & Francis
Aims Pembrolizumab has demonstrated significantly prolonged disease-free survival and
overall survival (OS) among adult patients post-nephrectomy who have an intermediate-high …
overall survival (OS) among adult patients post-nephrectomy who have an intermediate-high …
Three Versus Six Months of Adjuvant Oxaliplatin-Containing Chemotherapy for Patients With Stage III Colorectal Cancer: A Contemporary Real-World Analysis
T Krishnan, E Leung, JP Solar Vasconcelos… - JCO Oncology …, 2024 - ascopubs.org
PURPOSE Based on the International Duration Evaluation of Adjuvant Chemotherapy
analysis, 3 months of adjuvant chemotherapy with capecitabine and oxaliplatin (CAPOX) is …
analysis, 3 months of adjuvant chemotherapy with capecitabine and oxaliplatin (CAPOX) is …
Cost‐effectiveness of adjuvant chemotherapy for high‐risk stage II and stage III colon cancer in South Africa
SX Tan, Y Pumpalova, AM Rogers, K Bhatt… - Cancer …, 2023 - Wiley Online Library
Background Colon cancer incidence is rising in low‐and middle‐income countries (LMICs),
where resource limitations and cost often dictate treatment decisions. In this study, we …
where resource limitations and cost often dictate treatment decisions. In this study, we …